Chemical biology of intracellular cholesterol transport
ChemBioChol aims to develop selective small molecule modulators for cholesterol transport proteins to elucidate their roles in lipid metabolism and potential therapeutic applications in diseases.
Projectdetails
Introduction
Cholesterol transport proteins (CTPs) regulate cellular metabolism, hormone biosynthesis, and organelle contacts, with profound consequences for human health and disease. Despite this, almost no small molecule CTP modulators have been reported, and no methods for determining selectivity across the broader protein class exist.
Challenges in CTP Inhibition
Selective CTP inhibition is conceptually challenging as all CTPs are structurally similar and bind cholesterol. Furthermore, due to redundancy among several CTPs, deciphering the biological roles of their individual cholesterol transport activity has been difficult.
Project Overview
ChemBioChol aims to unravel the functions of individual CTPs by developing selective small molecule modulators. Based on seminal work from my lab, I propose employing a sterol-inspired compound design strategy consisting of:
- A primary sterol fragment as an “anchor” for CTP binding.
- Secondary natural product fragments to engineer selectivity of the compounds for individual CTPs.
Methodology
My group will develop bio-physical and -chemical tools to determine lipid selectivity of CTPs and optimize selective molecules against them. Preliminary data on the Aster CTP family provides a proof-of-principle that selective and potent chemical tools are attainable, and that the concept is applicable to further CTP families.
Cellular Selectivity Determination
To determine cellular selectivity of CTP inhibitors against all cholesterol-binding proteins, I will also develop a mass spectrometry-based chemical proteomic approach with a universal cholesterol probe.
Applications
Optimized CTP inhibitors will be used to determine how CTPs mediate lipid metabolism and trafficking, and their effect on sterol-mediated processes including mTOR signaling and autophagy, with potential applications in neurodegenerative disorders and cancer.
Impact
A general approach for selectively modulating CTPs is ground-breaking and will have impact beyond this set of proteins by providing a blueprint for studying and targeting other families of lipid-binding proteins in the future.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.786 |
Totale projectbegroting | € 1.499.786 |
Tijdlijn
Startdatum | 1-9-2022 |
Einddatum | 31-8-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- DANMARKS TEKNISKE UNIVERSITETpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A general approach for the design of covalent protein proximity inducersThis project aims to expand biochemical perturbations using CoLDR chemistry to create small molecules that activate enzymes, modify PTMs, and control protein interactions for therapeutic applications. | ERC Consolid... | € 1.998.744 | 2024 | Details |
An integral solution for quantifying intracellular lipid transport using close to native lipid probes.The project aims to develop high-throughput screening technologies to enhance understanding of lipid transport, facilitating drug design for diseases like fatty liver and benefiting society. | ERC Proof of... | € 150.000 | 2024 | Details |
Inhibitors of ECF transporters as novel antibacterial agentsThis project aims to develop novel antibacterial agents targeting ECF transporters in Gram-positive pathogens to combat antimicrobial resistance through a multidisciplinary approach. | ERC Proof of... | € 150.000 | 2024 | Details |
Determining the mechanisms of lipid-targeting antibiotics in intact bacteriaThis project aims to elucidate the mechanisms of lipid-targeting antibiotics using advanced imaging and NMR techniques to combat antimicrobial resistance effectively. | ERC Consolid... | € 2.000.000 | 2022 | Details |
CTP-dependent molecular switches: an emerging new principle in cellular regulationC SWITCH aims to explore the diverse roles of CTP-dependent C-switch proteins in cellular regulation and their potential as novel antibacterial targets to combat antibiotic resistance. | ERC Advanced... | € 2.082.419 | 2023 | Details |
A general approach for the design of covalent protein proximity inducers
This project aims to expand biochemical perturbations using CoLDR chemistry to create small molecules that activate enzymes, modify PTMs, and control protein interactions for therapeutic applications.
An integral solution for quantifying intracellular lipid transport using close to native lipid probes.
The project aims to develop high-throughput screening technologies to enhance understanding of lipid transport, facilitating drug design for diseases like fatty liver and benefiting society.
Inhibitors of ECF transporters as novel antibacterial agents
This project aims to develop novel antibacterial agents targeting ECF transporters in Gram-positive pathogens to combat antimicrobial resistance through a multidisciplinary approach.
Determining the mechanisms of lipid-targeting antibiotics in intact bacteria
This project aims to elucidate the mechanisms of lipid-targeting antibiotics using advanced imaging and NMR techniques to combat antimicrobial resistance effectively.
CTP-dependent molecular switches: an emerging new principle in cellular regulation
C SWITCH aims to explore the diverse roles of CTP-dependent C-switch proteins in cellular regulation and their potential as novel antibacterial targets to combat antibiotic resistance.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Universal GPCR Activity Sensor for Next Generation Drug DiscoveryThis project aims to develop a novel single-assay technology platform for GPCR drug discovery, enhancing detection and classification of drug candidates to improve efficacy and reduce failures. | EIC Pathfinder | € 2.965.384 | 2023 | Details |
Universal GPCR Activity Sensor for Next Generation Drug Discovery
This project aims to develop a novel single-assay technology platform for GPCR drug discovery, enhancing detection and classification of drug candidates to improve efficacy and reduce failures.